Long-term illness and patterns of medicine taking: Are people with schizophrenia a unique group?

Journal of Psychiatric and Mental Health Nursing

Volumn 8, Issue 3, 2001, Pages 197-204

  Marland, G R ^a   Cash, K ^b  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b LEEDS METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Compliance; Empowerment; Neuroleptics; Research; Schizophrenia

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; BEHAVIOR; CHRONIC DISEASE; HUMAN; NURSE PATIENT RELATIONSHIP; NURSING; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; RECURRENT DISEASE; SCHIZOPHRENIA; TREATMENT REFUSAL;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; HUMANS; NURSE-PATIENT RELATIONS; POWER (PSYCHOLOGY); RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT REFUSAL;

EID: 0035382793     PISSN: 13510126     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2850.2001.00389.x     Document Type: Article

References (51)

1. Adams C. & Eisenbruch M. (1997) Depot vs oral fluphenazine for schizophrenia (Cochrane Review). In: The Cochrane Library, Issue 4, 1998. Update Software, Oxford. (Date of most recent substantive amendment: 27 August .)
2. American Psychiatric Association (1994) Diagnostic and Statistical Manual. American Psychiatric Association, Babiker I.E. (1986) Non-compliance in schizophrenia. Psychiatric Developments 4, 329-337.
3. American Psychiatric Association (1994) Diagnostic and Statistical Manual. American Psychiatric Association, Babiker I.E. (1986) Non-compliance in schizophrenia. Psychiatric Developments 4, 329-337.
4. Barofsky I. (1978) Compliance, adherence and the therapeutic alliance: steps in the development of self-care. Social Science and Medicine 12, 369-376.
5. Bartko G., Herczeg I.J. & Zador G. (1988) Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatrica Scandinavica 77, 74-76.
6. Becker M.H. (1974) The Health Belief Model and Personal Health Behaviour. Thorafare, New Jersey.
7. Biley F.C. (1992) Some determinants that affect patient participation in decision-making about nursing care. Journal of Advanced Nursing 17, 414.
8. Buchanan A. (1992) A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine 22, 787-797.
9. Chewning B. & Sleath B. (1996) Medication decision-making and management: a client-centered model. Social Science and Medicine 42 (3), 389-398.
10. Corrigan S., Liberman R.P. & Engel J.D. (1990) From non-compliance to collaboration in the treatment of schizophrenia. Hospital and Community Psychiatry 41 (11), 1203-1211.
11. Cramer J. & Rosenheck R. (1998) Compliance with medication regimens for mental and physical disorders. Psychiatric Services 49 (2), 196-201.
12. Davidhizar R. & McBride A. (1985) Teaching the client with schizophrenia about medication. Patient Education and Counselling 7 (2), 137-145.
13. Drake R.E., Wallach M.A., Teague G.B., Freeman D.H., Paskus T.S. & Clark T.A. (1991) Housing instability and homelessness among rural schizophrenic patients. American Journal of Psychiatry 148, 330-336.
14. Eckman T.A. & Liberman R.P. (1991) A large-scale field test of a medication management skills training program for people with schizophrenia. Psychosocial Rehabilitation Journal 3, 31-35.
15. Eraker S.A., Kirscht J.P. & Becker M.H. (1984) Understanding and improving patient compliance. Annals of Internal Medicine 100, 258-268.
16. Falloon I. (1984) Developing and maintaining adherence to long-term drug taking regimes. Schizophrenia Bulletin 10 (3), 412-417.
17. Favrod J. (1993) Taking back control ... giving patients information about their drug regimes improves compliance. Nursing Times 89 (34: Mental Health), 68-70.
18. Festinger L. (1957) A Theory of Cognitive Dissonance. Stanford University Press, Stanford.
19. Green M. (1996) What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry 153, 321-330.
20. Haynes R., Taylor D. & Sackett D. (1979) Compliance in Health Care. The John Hopkins Pres, London.
21. Hofmann P., Melisch B., Zapotoczky H.G. & Kulhanek F. (1993) [Neuroleptic low-dose long-term strategy and intermittent therapy strategy in chronic schizophrenia - a critical review]. Fortschritte Neurologie-Psychiatrie 61 (6), 195-200.
22. Inui T.S., Yourtee E.L. & Williamson J.W. (1976) Improved outcomes in hypertension after physicians' tutorials: a controlled trial. Annals of Internal Medicine 84, 646-651.
23. Jarboe K. & Schwartz S. (1999) The relationship between medication noncompliance and cognitive function in patients with schizophrenia. Journal of the American Psychiatric Nurses Association 5, S2-S8.
24. Kemp R., Kirov G., Everitt B., Hayward P. & David A. (1998) Randomised controlled trial of compliance therapy (8-month follow up). British Journal of Psychiatry 172, 413-419.
25. Liberman R.P. & Eckman T.A. (1989) Dissemination of skills training modules to psychiatric facilities: overcoming obstacles to the utilisation of a rehabilitation innovation. British Journal of Psychiatry 155 (Suppl. 5), 117-122.
26. Lin I.F., Spiga R. & Fortsch W (1979) Insight and adherence to medication in chronic schizophrenics. Journal of Clinical Psychiatry 40, 430-432.
27. MacMillan F., Birchwood M. & Smith J. (1992) Predicting and controlling relapses in schizophrenia: early signs monitoring. In: Schizophrenia: an Overview and Practical Handbook (ed Kavinagh, D.J.), pp. 295-307. Chapman & Hall, London.
28. MacPherson R., Jerrom B. & Hughes A. (1997) Drug refusal among schizophrenic patients treated in the community. Journal of Mental Health 6 (2), 141-147.
29. Marder S.R., Mebane A., Chien C.P., Winslade W.J., Swann E. & Van Putten T. (1983) A comparison of patients who refuse and consent to neuroleptic treatment. American Journal of Psychiatry 140 (4), 470-472.
30. Marland G. (1999) Atypical neuroleptics: autonomy and compliance? Journal of Advanced Nursing 29 (30), 615-622.
31. Marland G. & Sharkey V. (1999) Depot neuroleptics, schizophrenia and the role of the nurse: is practice evidence based? Journal of Advanced Nursing 30 (6), 1255-1262.
32. McEvoy J.P., Apperson L.J., Applebaum P.S., Ortlip P., Brecosky J., Hammill K., Geller J.L. & Roth L. (1989) Insight in schizophrenia. Its relationship to acute psychopathology. Journal of Nervous and Mental Disease 177, 43-47.
33. Mullen P.D., Green L.W. & Persinger G.S. (1985) Clinical trials of patient education for chronic conditions: a comparative meta-analysis of intervention types. Preventive Medicine 14, 723-781.
34. Mushlin A.L. & Appel F.A. (1977) Diagnosing potential non-compliance: physicians' ability in a behavioural dimension of medical care. Archives of Internal Medicine 137, 318-321.
35. Nagy V.T. & Wolfe G.R. (1984) Cognitive predictors of compliance in chronic disease patients. Medical Care 22, 912-921.
36. Nelson A., Gold B., Hutchison R. & Benezra E. (1975) Drug default among schizophrenic patients. American Journal of Hospital Pharmacy 32, 1237-1242.
37. Park L.C. & Lipman R.S. (1964) A comparison of patient dosage deviation reports with pill counts. Psychopharmacologia 6, 299-302.
38. Pristach C.A. & Smith C.M. (1990) Medication compliance and substance abuse among schizophrenic patients. Hospital and Community Psychiatry 41, 1345-1348.
39. Renton C.A., Affleck J.W., Carstairs G.M. & Forrest A.D. (1963) A follow up of schizophrenic patients in Edinburgh. Acta Psychiatrica Scandinavica 39, 548-581.
40. Rich D. (1994) Relapse in the major mental disorders. Australian and New Zealand Journal of Mental Health Nursing 3 (4), 132-144.
41. Sackett D. & Haynes R. (1976) Compliance with Therapeutic Regimens. The Johns Hopkins University Press, Baltimore.
42. Schlenk E.A. & Hart L.K. (1984) Relationship between health locus of control, health value, and social support and compliance of persons with diabetes mellitus. Diabetes Care 7, 566-574.
43. Stanton A. (1987) Determinants of adherence to medical regimes by hypertensive patients. Journal of Behavioural Medicine 10, 377-394.
44. Stockwell Morris L. & Shulz R.M. (1992) Patient compliance -an overview. Journal of Clinical Pharmacy & Therapeutics 17, 283-295.
45. Swain D.L. & Steckel S.B. (1989) Influencing adherence among hypertensives. Research in Nursing and Health 4, 213-222.
46. Trostle J. (1988) Medical compliance as an ideology. Social Science and Medicine 27, 1299-1308.
47. Van Putten T. (1974) Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry 31, 67-72.
48. Van Putten T., Crumpton E. & Yale M. (1976) Drug refusal and the wish to be crazy. Archives of General Psychiatry 33, 1443-1445.
49. Wichowski H.C. & Kubsch S.M. (1997) The relationship of self-perception of illness and compliance with health care regimens. Journal of Advanced Nursing 25 (3), 548-553.
50. Wilson J.D. & Enoch M.D. (1967) Estimation of drug rejection by schizophrenic in-patients, with analysis of clinical findings. British Journal of Psychiatry 113, 209-211.
51. Winkleman N.W (1964) A clinical and socio-cultural study of 200 psychiatric patients started on chlorpromazine 10.5 years ago. American Journal of Psychiatry 120, 861-869.